Literature DB >> 16760805

What affects the recurrence and clinical outcome of pigmented villonodular synovitis?

Catharina Chiari1, Christian Pirich, Werner Brannath, Rainer Kotz, Klemens Trieb.   

Abstract

UNLABELLED: Studies investigating the outcome of pigmented villonodular synovitis have been restricted to certain locations or types of the disease and have not provided adequate documentation of followup. We asked the following questions: What were the recurrence rates especially when considering location and type of pigmented villonodular synovitis?; What was the long-term clinical outcome?; and Was MR imaging essential for the correct diagnosis? We retrospectively reviewed 42 of 53 consecutive patients primarily treated at our institution (19 diffuse lesions and 23 nodular lesions in 19 large joints and 23 digits of the hands or feet). Ten patients had recurrences after an average followup of 80 months (range, 26-293.8 months). Recurrences were more frequent for the diffuse type than the nodular type and in large joints rather than in digits. The average Enneking score was 92% of normal limb function indicating that surgical treatment led to good functional results. Preoperative magnetic resonance imaging results corresponded well with histologic diagnoses and intraoperative findings. LEVEL OF EVIDENCE: Therapeutic Level IV.

Entities:  

Mesh:

Year:  2006        PMID: 16760805     DOI: 10.1097/01.blo.0000224051.01873.fb

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  13 in total

Review 1.  [Pigmented villonodular synovitis. A rare differential diagnosis of synovial joint swelling].

Authors:  K A Jendrissek; T Hotfiel; B Swoboda; S Söder; R Janka
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

2.  Pigmented villonodular synovitis managed by total synovectomy and cementless total hip arthroplasty.

Authors:  Mohamed Mansour Elzohairy
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-04-26

3.  Pigmented villonodular synovitis: a crowdsourcing study of two hundred and seventy two patients.

Authors:  Lizz van der Heijden; Sheila R Piner; Michiel Adrianus Josephus van de Sande
Journal:  Int Orthop       Date:  2016-05-12       Impact factor: 3.075

4.  Tenosynovial Giant Cell Tumors in Children: A Similar Entity Compared With Adults.

Authors:  Monique J L Mastboom; Floortje G M Verspoor; Daniël Uittenbogaard; Gerard R Schaap; Paul C Jutte; H W Bart Schreuder; Michiel A J van de Sande
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

5.  Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.

Authors:  Dong-Eun Kim; Jong-Min Kim; Bum-Sik Lee; Nam-Ki Kim; Sang-Hoon Lee; Seong-Il Bin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-04-10       Impact factor: 4.342

6.  Outcomes after excision of pigmented villonodular synovitis of the knee.

Authors:  Vivek Sharma; Edward Y Cheng
Journal:  Clin Orthop Relat Res       Date:  2009-06-20       Impact factor: 4.176

7.  Surgical outcomes of 26 patients with pigmented villonodular synovitis (PVNS) of the knee at a mean follow-up of 4 years: introducing a novel technique.

Authors:  Mahmoud Jabalameli; Khodamorad Jamshidi; Mehran Radi; Hosseinali Hadi; Abolfazl Bagherifard
Journal:  Med J Islam Repub Iran       Date:  2014-10-29

8.  Arthroplasty for tenosynovial giant cell tumors.

Authors:  Floortje G M Verspoor; Gerjon Hannink; Anouk Scholte; Ingrid C M Van Der Geest; H W Bart Schreuder
Journal:  Acta Orthop       Date:  2016-06-30       Impact factor: 3.717

9.  Cryosurgery as Additional Treatment in Tenosynovial Giant Cell Tumors.

Authors:  F G M Verspoor; A Scholte; I C M van der Geest; G Hannink; H W B Schreuder
Journal:  Sarcoma       Date:  2016-12-26

10.  The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life.

Authors:  Monique Josephine Mastboom; Rosa Planje; Michiel Adreanus van de Sande
Journal:  Interact J Med Res       Date:  2018-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.